Arrowhead Pharmaceuticals, Inc. (ARWR)

NMS – Real Time Price. Currency in USD

79.04

+1.30 (1.67%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

829M

241M

243M

Cost of goods sold

-24M

-19M

-12M

-10M

Gross Profit

806M

-15M

228M

233M

Operating expenses (excl. COGS)

-707M

-586M

-433M

-411M

Operating Income

98M

-601M

-205M

-179M

Non-operating income, total

-47M

-11M

-1M

Pretax income

52M

-612M

-206M

-173M

Equity in earnings

Taxes

-21M

-3M

-4M

Non-controlling/minority interest

-32M

10M

431K

After tax other income/expense

Net income before discontinued operations

-2M

-599M

-205M

-176M

Arrowhead Pharmaceuticals, Inc. (ARWR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Arrowhead Pharmaceuticals, Inc. (ARWR)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Arrowhead Pharmaceuticals, Inc. (ARWR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Arrowhead Pharmaceuticals, Inc. (ARWR)

Income Statement (Annual)

Income Statement (Annual)